These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15298630)

  • 21. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal anti-inflammatory drugs and gastrointestinal bleeding.
    Lanas A
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S37-42. PubMed ID: 10379468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs.
    Walker AM
    Arthritis Rheum; 1997 Feb; 40(2):201-8. PubMed ID: 9041931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update of hepatotoxicity due to classes of drugs in common clinical use: non-steroidal drugs, anti-inflammatory drugs, antibiotics, antihypertensives, and cardiac and psychotropic agents.
    Zimmerman HJ
    Semin Liver Dis; 1990 Nov; 10(4):322-38. PubMed ID: 2281340
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatotoxicity of antirheumatic drugs.
    Tolman KG
    J Rheumatol Suppl; 1990 May; 22():6-11. PubMed ID: 2192059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori eradication may reduce the risk of gastroduodenal lesions in chronic NSAID users.
    Russell RI
    Ital J Gastroenterol Hepatol; 1997 Oct; 29(5):465-9. PubMed ID: 9494858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physicians' approaches to the use of gastroprotective strategies in low-risk non-steroidal anti-inflammatory drug users.
    Murthy SK; Kauldher S; Targownik LE
    Aliment Pharmacol Ther; 2006 May; 23(9):1365-72. PubMed ID: 16629943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross hepatotoxicity between non-steroidal anti-inflammatory drugs.
    Andrejak M; Davion T; Gineston JL; Capron JP
    Br Med J (Clin Res Ed); 1987 Jul; 295(6591):180-1. PubMed ID: 3115366
    [No Abstract]   [Full Text] [Related]  

  • 30. [Non-steroidal anti-inflammatory drugs. Adverse effects of non-steroidal anti-inflammatory drugs].
    Yamada Y; Kiyokawa S; Mizushima Y
    Nihon Rinsho; 1987 May; 45(5):1102-8. PubMed ID: 2957526
    [No Abstract]   [Full Text] [Related]  

  • 31. Non-steroidal anti-inflammatories and the development of analgesic nephropathy: a systematic review.
    Yaxley J; Litfin T
    Ren Fail; 2016 Oct; 38(9):1328-1334. PubMed ID: 27494231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver damage with non-narcotic analgesics.
    Prescott LF
    Med Toxicol; 1986; 1 Suppl 1():44-56. PubMed ID: 3547001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of non-steroidal anti-inflammatory drugs and risk of chronic kidney disease in people with Type 2 diabetes mellitus, a nationwide longitudinal cohort study.
    Tsai HJ; Hsu YH; Huang YW; Chang YK; Liu JS; Hsu CC
    Diabet Med; 2015 Mar; 32(3):382-90. PubMed ID: 25313684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The natural history of histologically proved drug induced liver disease.
    Aithal PG; Day CP
    Gut; 1999 May; 44(5):731-5. PubMed ID: 10205214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case-crossover design: an alternative strategy for detecting drug-induced liver injury.
    Lee CH; Wang JD; Chen PC;
    J Clin Epidemiol; 2012 May; 65(5):560-7. PubMed ID: 22445086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining patients at risk of non-steroidal anti-inflammatory drug gastropathy.
    Russell RI
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S14-8. PubMed ID: 10379464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of NSAID-induced hepatotoxicity: focus on nimesulide.
    Boelsterli UA
    Drug Saf; 2002; 25(9):633-48. PubMed ID: 12137558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonsteroidal anti-inflammatory drug-induced hepatic disorders. Incidence and prevention.
    Manoukian AV; Carson JL
    Drug Saf; 1996 Jul; 15(1):64-71. PubMed ID: 8862964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced liver injury due to antimicrobials, central nervous system agents, and nonsteroidal anti-inflammatory drugs.
    Devarbhavi H; Andrade RJ
    Semin Liver Dis; 2014 May; 34(2):145-61. PubMed ID: 24879980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis due to nonsteroidal anti-inflammatory agents].
    Furet Y; Metman EH; Breteau M; Bertrand J
    Ann Gastroenterol Hepatol (Paris); 1987 Dec; 23(7):367-74. PubMed ID: 3324927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.